Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
21 Results for "
CYCS
" in MedChemExpress (MCE) Product Catalog:
Products (21)
21 Results for "CYCS" in MCE Product Catalog:
6
6 Publications Verification
Synonyms: CYC065
Fadraciclib (CYC065) is a second-generation, orally available ATP-competitive inhibitor of CDK2/CDK9 kinases with IC50s of 5 and 26 nM, respectively .
4
4 Cited Publications
Target:
Research Areas:
CYC-116 is a potent aurora A and aurora B inhibitor with Kis of 8 and 9 nM, respectively.
2
1
Target:
Research Areas:
Plogosertib (CYC140) is a selective, potent, and orally active ATP-competitive PLK1 inhibitor (IC50: 3 nM). Plogosertib is an anti-cancer agent with anti-proliferative activity. Plogosertib can be used in the research of several tumors, including esophageal, gastric, leukemia, non–small cell lung cancer, ovarian, and squamous cell cancers .
1
1 Cited Publications
Synonyms: (S)-Seliciclib; (S)-CYC202
Target:
Research Areas:
(S)-Roscovitine ((S)-Seliciclib; (S)-CYC202) is a potent and cross the blood-brain barrier CDKs inhibitor. (S)-Roscovitine shows neuroprotective efficacy. (S)-Roscovitine has the potential for the research of stroke .
CDK1/Cyc B-IN-1 (Compound 5) is a selective CDK1/Cyc B complex inhibitor with an IC50 of 97 nM. CDK1/Cyc B-IN-1 triggers apoptosis and G2/M cell cycle arrest. CDK1/Cyc B-IN-1 shows broad-spectrum cytotoxic action against cancer cell lines .
Cat. No.: HY-RS03428
Target:
Research Areas:
CYC1 Human Pre-designed siRNA Set A contains three designed siRNAs for CYC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS03429
Target:
Research Areas:
CYCS Human Pre-designed siRNA Set A contains three designed siRNAs for CYCS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-173600
CAS No.: 497071-98-4
Target:
Research Areas:
CYCS-INPP4A interaction-IN-1 (10A3) disrupts the CYCS-INPP4A interaction complex and enhances ferroptosis-mediated tumor suppression .
Cat. No.: HY-RS17636
Target:
Research Areas:
Cyc1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cyc1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS20264
Target:
Research Areas:
Cycs Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cycs gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS26772
Target:
Research Areas:
Cycs Rat Pre-designed siRNA Set A contains three designed siRNAs for Cycs gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-10558R
CAS No.: 693228-63-6
Target:
Research Areas:
CYC-116 (Standard) is the analytical standard of CYC-116 (HY-10558). This product is intended for research and analytical applications. CYC-116 is a potent aurora A and aurora B inhibitor with Kis of 8 and 9 nM, respectively.
Cat. No.: HY-RS24096
Target:
Research Areas:
Cyc1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Cyc1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-N17698
CAS No.: 86541-83-5
Synonyms: Cyc B
Category:
Target:
Cat. No.: HY-101212R
CAS No.: 1070790-89-4
Synonyms: CYC065 (Standard)
Target:
Research Areas:
Fadraciclib (Standard) is the analytical standard of Fadraciclib (HY-101212). This product is intended for research and analytical applications. Fadraciclib (CYC065) is a second-generation, orally available ATP-competitive inhibitor of CDK2/CDK9 kinases with IC50s of 5 and 26 nM, respectively .
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
